Clinical Trial Update: Zoledronate in Preventing Bone Loss in Postmenopausal Women Who Are Receiving Letrozole for Stage I, Stage II, or Stage IIIA Breast Cancer [Phase 3]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 3 study evaluating zoledronate to prevent bone loss in postmenopausal women with breast cancer who …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Osteoporosis

Drugs mentioned

• Letrozole (letrozole)
• Zoledronate (zoledronic acid)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Breast Cancer, Osteoporosis | Phase 3 | Status: COMPLETED